Status:
COMPLETED
NovoLet® Acceptance Study Within the Hospital Practise in Indonesia
Lead Sponsor:
Novo Nordisk A/S
Conditions:
Diabetes
Diabetes Mellitus, Type 1
Eligibility:
All Genders
18+ years
Brief Summary
This study is conducted in Asia. The aim of this study is to evaluate the overall acceptance of healthcare professionals (nurses and doctors) to the NovoLet® system used in a hospital environment.
Eligibility Criteria
Inclusion
- Inclusion Criteria:
- Type 1 diabetes
- Type 2 diabetes
- Likely to be hospitalised and require insulin therapy
Exclusion
Key Trial Info
Start Date :
September 1 2005
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
June 1 2006
Estimated Enrollment :
203 Patients enrolled
Trial Details
Trial ID
NCT01492205
Start Date
September 1 2005
End Date
June 1 2006
Last Update
October 14 2016
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Novo Nordisk Investigational Site
Jakarta, Indonesia, 12520